🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Lichen Planopilaris

Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study. NCT07396168Phase 41 site📍 New City The Skin Center Dermatology Group · Tests: Nemolizumab A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris NCT07532603Phase 2, Phase 361 sites📍 Birmingham📍 Phoenix📍 Scottsdale Priovant Therapeutics, Inc. · Tests: Oral Brepocitinib, Placebo Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris NCT07487948Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Delgocitinib Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study. NCT07492251Phase 25 sites📍 Nice📍 Paris📍 Reims Centre Hospitalier Universitaire de Nice · Tests: Upadacitinib, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy